Man kan sidde og blive forundret over BioPorto´s nyansættelser i USA, i forbindelse med opstarten af deres amerikanske salgskontor. Disse 3 er alle tidligere ansatte hos Abbott, og den første, Lisa Anselmino var efter mit bedste bud, hende BioPorto burde ha forhandlet den helt store distributionsaftale med, såfremt. Mon ikke hun kan vise sig nyttig på anden vis, når hun nu arbejder for os.
Jeg synes det er voldsom interessant, at PME har formået at tiltrække så kvalificeret arbejdskraft, jeg tager hatten af.. Disse 3, må om nogen have kendskab til branchen, og vurderet Ngal særdeles interessant, nu de fortsætter deres karriere i et ganske lille dansk selskab. Lisa Anselmino har været chef for den 4 Mia dollar store licensafdeling hos Abbott diagnostic division. - jeg synes det er direkte vanvittigt at hendes nye jobtitel er " BioPorto Diagnostics, BioActive Business Advisors LLC". Det ser ud som om Lisa er startet som selvstændig konsulent, og direkte knyttet til BioPortos´s opstart i USA.
https://www.linkedin.com/in/anselmino1
Lisa Anselmino:
Founder/Principal at BioActive Business Advisors LLC
Chicago-området, USA
Hospital og sundhedspleje
Nuværende
1. BioPorto Diagnostics,
2. BioActive Business Advisors LLC
Forrige
1. Abbott Laboratories
Uddannelse
1. Rush University
Kort beskrivelse
Accomplished executive with extensive experience in evaluating strategic business opportunities and executing deals in the Diagnostic division of a Fortune 100 healthcare company. Demonstrated record of excellence in negotiating complex deals including; technology, patent and know-how licensing (in/out); companion diagnostic/personalized medicine deals, supply and third party manufacturing deals, settlements and acquisition and divestiture activities. Reputation as results oriented, creative thinker, sees big picture as well as critical details. Worked with senior executives both inside and outside of company and coordinated efforts across company divisions and global functions such as Sales/Marketing, R&D, Business Development, Legal, Finance, Quality and Regulatory. Enjoys developing creative solutions to meet business objectives. Proven ability to effectively lead a team of people and deliver results.
Areas of expertise:
Licensing / Diagnostics / Business Development / Personalized Medicine / Healthcare / Technology Assessment / Strategic Alliances / Acquisitions / Divestitures / Research & Development / R&D / Strategic Planning / Biomarkers / Companion Diagnostics / Intellectual Property / Cross-functional teams / Competitive Intelligence / Negotiations / Alliance Management
Sr. Director, Business Development
BioPorto Diagnostics
januar 2016 - i dag (3 måneder)Chicago, IL
Founder/Principal
BioActive Business Advisors LLC
december 2015 - i dag (4 måneder)
Sr. Director, Global Licensing
Abbott Laboratories
2007 - december 2015 (8 år)Lake Forest, IL
Headed up the licensing department for the >$4B Diagnostic Division of Abbott Laboratories and personally executed key complex global deals to provide access to new business segments. Led cross-functional teams to evaluate external opportunities and delivered recommendations to Sr. Management and President. Managed divisional licensing budget, oversaw royalty payment process, and assured OEC and Corporate Purchasing compliance adherence.
Accomplishments: Executed key deals to set up strategic relationships, R&D partnerships, supply agreements, clinical evaluations, technology and intellectual property acquisitions to enable Abbott to enter new market segments or further expand its product offerings.
Director, Licensing and Intellectual Property
Abbott Laboratories
2001 - 2007 (6 år)Abbott Park, IL
Responsibilities: Led transactional group that executed significant global deals and developed strategic IP initiatives.
Accomplishments: Managed a group of up to 12 licensing/contract specialists. Led an out-licensing program that generated significant income. Developed a strategic Intellectual Property (IP) group and divisional program (education/incentives) which resulted in development of a patent governance board, increased IP awareness and patent filings in the division. Lead negotiator on third party manufacturing deals for over 12 products that provided significant revenue to the LRP.
Various positions of increasing responsibility in Licensing & Technology Acquisitions Department.
Abbott Laboratories
1996 - 2007 (11 år)Abbott Park, IL
Negotiated key deals for cardiac and oncology markers. Led due diligence activities for the acquisition of Vysis (now Abbott Molecular) and on divestiture teams for the Bacteriology and Rapid Product businesses.
John Baird
https://www.linkedin.com/in/john-baird-bb9a2520?authType=NAME_SEARCH&authToken=CjNQ&locale=en_US&srchid=3590128461457955856661&srchindex=4&srchtotal=381&trk=vsrp_people_res_name&trkInfo=VSRPsearchId%3A3590128461457955856661%2CVSRPtargetId%3A74203773%2CVSRPcmpt%3Aprimary%2CVSRPnm%3Atrue%2CauthType%3ANAME_SEARCH
Sale Director - Area West at BioPorto Diagnostics A/S
Denver-området, USA
Medicinsk udstyr
Nuværende
1. BioPorto Diagnostics A/S
Forrige
1. Critical Diagnostics,
2. Gambo: Aquapheresis Systems,
3. Unisyn Medical Technologies
Uddannelse
1. New York Medical College
Erfaring
Sale Director - Area West
BioPorto Diagnostics A/S
februar 2016 - i dag (2 måneder)Denver-området, USA
BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. Our pioneering product portfolio includes assays for underserved disease states such as NGAL for acute kidney injury. We sell our products in more than 80 countries through diverse sales channels and partners. BioPorto has its headquarters in Copenhagen, Denmark and is listed on the NASDAQ OMX Copenhagen stock exchange.
Senior Vice President for Sales and Business Development
Critical Diagnostics
oktober 2012 - januar 2016 (3 år 4 måneder)Denver-området, USA
About Critical Diagnostics
Critical Diagnostics helps physicians optimize patient care in cardiovascular diseases, such as heart failure. Our high sensitivity Presage® ST2 Assay measures the level of soluble ST2 in blood, identifying patients at increased risk of adverse events and mortality. ST2 has been evaluated in multiple clinical studies, now spanning more than 31,000 subjects.
ST2 signals the presence of adverse cardiac remodeling and fibrosis, which occur in response to myocardial infarction (MI), ischemia, or worsening heart failure. Remodeling and fibrosis can also contribute to the development of future adverse events, such as secondary MI or sudden cardiac death (SCD), and to progression of heart failure. The Presage® ST2 Assay quantitatively measures the concentration of soluble ST2, providing a physician with an accurate tool to assess prognosis in patients with heart failure.
The Presage® ST2 Assay helps clinicians assess patient prognosis in order to better personalize their care. By selecting the most appropriate treatments and interventions for each patient, a physician can maximize the clinical benefit from increasingly limited healthcare resources.
Critical Diagnostics is headquartered in San Diego, California.
Specialties: InVitro Diagnostics, Cardiac Diseases
Website: http://www.criticaldiagnostics.com
Founded: 2004
West Regional Manager
Gambo: Aquapheresis Systems
maj 2011 - juli 2012 (1 år 3 måneder)
VP of Marketing and Business Development
Unisyn Medical Technologies
juli 2008 - maj 2011 (2 år 11 måneder)
VP of Sales and Marketing
Inovise Medical, Inc.
2005 - 2008 (3 år)
Director of Marketing
Biosite
2003 - 2005 (2 år)
Director of Global Marketing
Abbott Diagnostics
1989 - 2003 (14 år)
Jim Casey
https://www.linkedin.com/in/jimcaseyexecprofile
Vice President Sales at BioPorto Diagnostics
Chicago-området, USA
Medicinsk udstyr
Nuværende
1. BioPorto Diagnostics A/S
Forrige
1. Abbott
Uddannelse
1. University of Chicago
Kort beskrivelse
Experienced In Vitro Diagnostics executive with extensive experience in
• Business development
• Contracting and licensing
• Product development and launch
• Commercial launch execution
Specialties: New Product Development and Launch
Biomarker market development
Erfaring
Vice President Sales
BioPorto Diagnostics A/S
marts 2016 - i dag (1 måned)Chicago-området, USA
Establish and lead US sales team for BioPorto Diagnostics with focus on commercialization of The NGAL Test to aid in the diagnosis of Acute Kidney Injury (under FDA review).
Sr Product Manager
Abbott
marts 2015 - februar 2016 (1 år)Des Plaines IL
Responsible to lead marketing activities for development of assay menu content on Abbott Molecular's Next Generation System including launch roll out plans, performance characteristics, positioning versus competition, etc. Identify user needs and product requirements for molecular assay content through the execution of international advisory board meetings and competitive assessments. Develop customer segmentation strategies and tools,
Sr. Product Manager, Global Marketing
Abbott Molecular
august 2011 - februar 2015 (3 år 7 måneder)Des Plaines IL
Responsible to define and direct the implementation of all aspects of the Abbott Molecular Hepatitis product strategy.
Strategic Sourcing Director
Abbott Diagnostics
2006 - september 2011 (5 år)
Manage overall immunoassay outsourcing strategy and business relationships for TPMs for Abbott Diagnostics representing over $70MM in spend supporting almost $400MM in 2010 sales. Primary contact for external supplier's executive management.
Business Development Manager
Abbott Diagnostics
2003 - 2006 (3 år)
Drove business development activities for outsourcing for Abbott Diagnostics including strategy development, identification and development of key strategic partnerships, financial analysis and market assessment for new business opportunities, contract negotiations, new product development and launch, post launch marketing and product management support.
Marketing Manager
Abbott Diagnostics
2001 - 2003 (2 år)
Executed all aspects of new product development and launch including; market assessment, vendor identification, contract negotiation, product design goals, product labeling and packaging, operations and logistics activities, pre-launch customer use trials, and sales and marketing materials.
Jeg synes det er voldsom interessant, at PME har formået at tiltrække så kvalificeret arbejdskraft, jeg tager hatten af.. Disse 3, må om nogen have kendskab til branchen, og vurderet Ngal særdeles interessant, nu de fortsætter deres karriere i et ganske lille dansk selskab. Lisa Anselmino har været chef for den 4 Mia dollar store licensafdeling hos Abbott diagnostic division. - jeg synes det er direkte vanvittigt at hendes nye jobtitel er " BioPorto Diagnostics, BioActive Business Advisors LLC". Det ser ud som om Lisa er startet som selvstændig konsulent, og direkte knyttet til BioPortos´s opstart i USA.
https://www.linkedin.com/in/anselmino1
Lisa Anselmino:
Founder/Principal at BioActive Business Advisors LLC
Chicago-området, USA
Hospital og sundhedspleje
Nuværende
1. BioPorto Diagnostics,
2. BioActive Business Advisors LLC
Forrige
1. Abbott Laboratories
Uddannelse
1. Rush University
Kort beskrivelse
Accomplished executive with extensive experience in evaluating strategic business opportunities and executing deals in the Diagnostic division of a Fortune 100 healthcare company. Demonstrated record of excellence in negotiating complex deals including; technology, patent and know-how licensing (in/out); companion diagnostic/personalized medicine deals, supply and third party manufacturing deals, settlements and acquisition and divestiture activities. Reputation as results oriented, creative thinker, sees big picture as well as critical details. Worked with senior executives both inside and outside of company and coordinated efforts across company divisions and global functions such as Sales/Marketing, R&D, Business Development, Legal, Finance, Quality and Regulatory. Enjoys developing creative solutions to meet business objectives. Proven ability to effectively lead a team of people and deliver results.
Areas of expertise:
Licensing / Diagnostics / Business Development / Personalized Medicine / Healthcare / Technology Assessment / Strategic Alliances / Acquisitions / Divestitures / Research & Development / R&D / Strategic Planning / Biomarkers / Companion Diagnostics / Intellectual Property / Cross-functional teams / Competitive Intelligence / Negotiations / Alliance Management
Sr. Director, Business Development
BioPorto Diagnostics
januar 2016 - i dag (3 måneder)Chicago, IL
Founder/Principal
BioActive Business Advisors LLC
december 2015 - i dag (4 måneder)
Sr. Director, Global Licensing
Abbott Laboratories
2007 - december 2015 (8 år)Lake Forest, IL
Headed up the licensing department for the >$4B Diagnostic Division of Abbott Laboratories and personally executed key complex global deals to provide access to new business segments. Led cross-functional teams to evaluate external opportunities and delivered recommendations to Sr. Management and President. Managed divisional licensing budget, oversaw royalty payment process, and assured OEC and Corporate Purchasing compliance adherence.
Accomplishments: Executed key deals to set up strategic relationships, R&D partnerships, supply agreements, clinical evaluations, technology and intellectual property acquisitions to enable Abbott to enter new market segments or further expand its product offerings.
Director, Licensing and Intellectual Property
Abbott Laboratories
2001 - 2007 (6 år)Abbott Park, IL
Responsibilities: Led transactional group that executed significant global deals and developed strategic IP initiatives.
Accomplishments: Managed a group of up to 12 licensing/contract specialists. Led an out-licensing program that generated significant income. Developed a strategic Intellectual Property (IP) group and divisional program (education/incentives) which resulted in development of a patent governance board, increased IP awareness and patent filings in the division. Lead negotiator on third party manufacturing deals for over 12 products that provided significant revenue to the LRP.
Various positions of increasing responsibility in Licensing & Technology Acquisitions Department.
Abbott Laboratories
1996 - 2007 (11 år)Abbott Park, IL
Negotiated key deals for cardiac and oncology markers. Led due diligence activities for the acquisition of Vysis (now Abbott Molecular) and on divestiture teams for the Bacteriology and Rapid Product businesses.
John Baird
https://www.linkedin.com/in/john-baird-bb9a2520?authType=NAME_SEARCH&authToken=CjNQ&locale=en_US&srchid=3590128461457955856661&srchindex=4&srchtotal=381&trk=vsrp_people_res_name&trkInfo=VSRPsearchId%3A3590128461457955856661%2CVSRPtargetId%3A74203773%2CVSRPcmpt%3Aprimary%2CVSRPnm%3Atrue%2CauthType%3ANAME_SEARCH
Sale Director - Area West at BioPorto Diagnostics A/S
Denver-området, USA
Medicinsk udstyr
Nuværende
1. BioPorto Diagnostics A/S
Forrige
1. Critical Diagnostics,
2. Gambo: Aquapheresis Systems,
3. Unisyn Medical Technologies
Uddannelse
1. New York Medical College
Erfaring
Sale Director - Area West
BioPorto Diagnostics A/S
februar 2016 - i dag (2 måneder)Denver-området, USA
BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. Our pioneering product portfolio includes assays for underserved disease states such as NGAL for acute kidney injury. We sell our products in more than 80 countries through diverse sales channels and partners. BioPorto has its headquarters in Copenhagen, Denmark and is listed on the NASDAQ OMX Copenhagen stock exchange.
Senior Vice President for Sales and Business Development
Critical Diagnostics
oktober 2012 - januar 2016 (3 år 4 måneder)Denver-området, USA
About Critical Diagnostics
Critical Diagnostics helps physicians optimize patient care in cardiovascular diseases, such as heart failure. Our high sensitivity Presage® ST2 Assay measures the level of soluble ST2 in blood, identifying patients at increased risk of adverse events and mortality. ST2 has been evaluated in multiple clinical studies, now spanning more than 31,000 subjects.
ST2 signals the presence of adverse cardiac remodeling and fibrosis, which occur in response to myocardial infarction (MI), ischemia, or worsening heart failure. Remodeling and fibrosis can also contribute to the development of future adverse events, such as secondary MI or sudden cardiac death (SCD), and to progression of heart failure. The Presage® ST2 Assay quantitatively measures the concentration of soluble ST2, providing a physician with an accurate tool to assess prognosis in patients with heart failure.
The Presage® ST2 Assay helps clinicians assess patient prognosis in order to better personalize their care. By selecting the most appropriate treatments and interventions for each patient, a physician can maximize the clinical benefit from increasingly limited healthcare resources.
Critical Diagnostics is headquartered in San Diego, California.
Specialties: InVitro Diagnostics, Cardiac Diseases
Website: http://www.criticaldiagnostics.com
Founded: 2004
West Regional Manager
Gambo: Aquapheresis Systems
maj 2011 - juli 2012 (1 år 3 måneder)
VP of Marketing and Business Development
Unisyn Medical Technologies
juli 2008 - maj 2011 (2 år 11 måneder)
VP of Sales and Marketing
Inovise Medical, Inc.
2005 - 2008 (3 år)
Director of Marketing
Biosite
2003 - 2005 (2 år)
Director of Global Marketing
Abbott Diagnostics
1989 - 2003 (14 år)
Jim Casey
https://www.linkedin.com/in/jimcaseyexecprofile
Vice President Sales at BioPorto Diagnostics
Chicago-området, USA
Medicinsk udstyr
Nuværende
1. BioPorto Diagnostics A/S
Forrige
1. Abbott
Uddannelse
1. University of Chicago
Kort beskrivelse
Experienced In Vitro Diagnostics executive with extensive experience in
• Business development
• Contracting and licensing
• Product development and launch
• Commercial launch execution
Specialties: New Product Development and Launch
Biomarker market development
Erfaring
Vice President Sales
BioPorto Diagnostics A/S
marts 2016 - i dag (1 måned)Chicago-området, USA
Establish and lead US sales team for BioPorto Diagnostics with focus on commercialization of The NGAL Test to aid in the diagnosis of Acute Kidney Injury (under FDA review).
Sr Product Manager
Abbott
marts 2015 - februar 2016 (1 år)Des Plaines IL
Responsible to lead marketing activities for development of assay menu content on Abbott Molecular's Next Generation System including launch roll out plans, performance characteristics, positioning versus competition, etc. Identify user needs and product requirements for molecular assay content through the execution of international advisory board meetings and competitive assessments. Develop customer segmentation strategies and tools,
Sr. Product Manager, Global Marketing
Abbott Molecular
august 2011 - februar 2015 (3 år 7 måneder)Des Plaines IL
Responsible to define and direct the implementation of all aspects of the Abbott Molecular Hepatitis product strategy.
Strategic Sourcing Director
Abbott Diagnostics
2006 - september 2011 (5 år)
Manage overall immunoassay outsourcing strategy and business relationships for TPMs for Abbott Diagnostics representing over $70MM in spend supporting almost $400MM in 2010 sales. Primary contact for external supplier's executive management.
Business Development Manager
Abbott Diagnostics
2003 - 2006 (3 år)
Drove business development activities for outsourcing for Abbott Diagnostics including strategy development, identification and development of key strategic partnerships, financial analysis and market assessment for new business opportunities, contract negotiations, new product development and launch, post launch marketing and product management support.
Marketing Manager
Abbott Diagnostics
2001 - 2003 (2 år)
Executed all aspects of new product development and launch including; market assessment, vendor identification, contract negotiation, product design goals, product labeling and packaging, operations and logistics activities, pre-launch customer use trials, and sales and marketing materials.
